{"entity":{"id":"paper-wielzen-prostate-cancer-suriname-jcogo-2026","kind":"paper","name":"Ethnic and Geographic Variation in Prostate Cancer Presentation in Suriname","aka":[],"tldr":"Among 570 men with prostate cancer confirmed in Suriname's national pathology database from 2018 to 2023, 41% had high-grade disease and the median PSA at diagnosis was 21 ng/mL.","summary":"A retrospective analysis of histologically confirmed prostate adenocarcinoma from the National Pathology Database of Suriname, 2018 to 2023, with age, ethnicity, PSA level, grade group and district of residence (remote or not). Multivariable logistic regression looked for factors associated with high-grade disease (grade groups 4 and 5).","asOf":"2026-11-16","links":[{"label":"DOI","url":"https://doi.org/10.1200/go-26-00274"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/42814916/"}],"tags":[],"related":["paper-mans-cancer-incidence-suriname-tumori-2003","paper-bisheshar-head-neck-cancer-suriname-jcogo-2025"],"cancers":["prostate"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["azp-suriname","moh-suriname"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"journal":"JCO Global Oncology","year":2026,"doi":"10.1200/go-26-00274","pmid":"42814916","authors":"Wielzen HA, Sandel NJ, Ramsoekh A, et al.","paperType":"observational","findings":["570 patients, median age 69 years; 40.9% had high-grade disease and the overall median PSA was 21.0 ng/mL (interquartile range 12.0 to 47.4).","Median PSA did not differ between African-ancestry and Asian-ancestry groups (21.0 against 20.3 ng/mL).","In the regression (331 patients), Javanese ethnicity was associated with high-grade disease compared with Creole ethnicity (adjusted odds ratio 3.31, 95% CI 1.31 to 8.39).","Patients from remote districts had numerically higher PSA and more high-grade disease, without statistical significance."],"whatItMeans":"Many men in Suriname are diagnosed with prostate cancer when it is already high grade; the authors describe the differences between groups as hypothesis generating.","caveats":["Only biopsy-confirmed cases, so men never biopsied are missing.","The regression used 331 of the 570 patients.","No information on stage, treatment or outcome in the abstract."],"participants":570},"route":"/key-papers/paper-wielzen-prostate-cancer-suriname-jcogo-2026/","neighbours":{"paper":[{"id":"paper-mans-cancer-incidence-suriname-tumori-2003","kind":"paper","name":"Cancer incidence in Suriname from 1980 through 2000 a descriptive study","route":"/key-papers/paper-mans-cancer-incidence-suriname-tumori-2003/"},{"id":"paper-bisheshar-head-neck-cancer-suriname-jcogo-2025","kind":"paper","name":"Head and Neck Cancer in Suriname: An Epidemiologic Review of Clinical and Pathologic Features of Patients Treated Between 2009 and 2021","route":"/key-papers/paper-bisheshar-head-neck-cancer-suriname-jcogo-2025/"}],"cancer":[{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"institution":[{"id":"azp-suriname","kind":"institution","name":"Academisch Ziekenhuis Paramaribo","route":"/institutions/azp-suriname/"},{"id":"moh-suriname","kind":"institution","name":"Ministry of Health, Suriname","route":"/institutions/moh-suriname/"}]}}